financetom
Business
financetom
/
Business
/
Bezos' Blue Origin prepares for debut New Glenn rocket launch
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bezos' Blue Origin prepares for debut New Glenn rocket launch
Jan 12, 2025 10:17 PM

CAPE CANAVERAL, Florida (Reuters) - Jeff Bezos' Blue Origin prepared for the inaugural launch of its New Glenn rocket from Florida early on Monday, nearing a pivotal debut in Earth orbit that will mark a major step towards a long-awaited goal of competing with Elon Musk's SpaceX in the satellite launch market.

Standing 30 stories tall, the partially reusable New Glenn launcher sat on Blue Origin's launchpad at the Cape Canaveral Space Force Station, ready for its 1:30 am ET (0630 GMT) liftoff after being loaded with methane and liquid oxygen propellants.

The mission, the culmination of a decade-long, multi-billion-dollar development journey, will include an attempt to land New Glenn's first stage booster on a sea-fairing barge in the Atlantic Ocean 10 minutes after liftoff, while the rocket's second stage continues toward orbit.

"The thing we're most nervous about is the booster landing," Bezos, who founded Blue Origin in 2000, told Reuters in a pre-launch interview. "Clearly on a first flight you could have an anomaly at any mission phase, so anything could happen."

Secured inside New Glenn's payload bay is the first prototype of Blue Origin's Blue Ring vehicle, a maneuverable spacecraft the company plans to sell to the Pentagon and commercial customers for national security and satellite servicing missions.

Getting the spacecraft to its intended orbit on an inaugural rocket launch would be a rare achievement for a space company.

"If we could do that, that would be a great success," Bezos said. "Landing the booster would be icing on the cake."

The development of New Glenn has spanned three Blue Origin CEOs and faced numerous delays as Elon Musk's SpaceX grew into an industry juggernaut with its reusable Falcon 9, the world's most active rocket.

Bezos in late 2023 moved to speed things up at Blue Origin, prioritizing the development of New Glenn and its BE-4 engines. He named Dave Limp, an Amazon ( AMZN ) veteran, as CEO, who employees say introduced a sense of urgency to compete with SpaceX.

New Glenn is more than twice as powerful as SpaceX's Falcon 9 rocket and has dozens of customer launch contracts collectively worth billions of dollars lined up.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Denison Mines Reports Q2 Earnings, Unchanged Revenue
Denison Mines Reports Q2 Earnings, Unchanged Revenue
Aug 8, 2025
05:43 AM EDT, 08/08/2025 (MT Newswires) -- Denison Mines ( DNN ) reported Q2 earnings from continuing operations late Thursday of 0.01 Canadian dollar ($0.007) per diluted share, swinging from a CA$0.02 loss a year earlier. Analysts' estimates were unavailable for comparison. Revenue for the quarter ended June 30 was CA$1.3 million, unchanged from a year earlier. An analyst polled...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Novo Nordisk Stock Climbs Over 4% In Friday Pre-Market: What's Going On?
Novo Nordisk Stock Climbs Over 4% In Friday Pre-Market: What's Going On?
Aug 8, 2025
Shares of Novo Nordisk A/S ( NVO ) climbed 4.29% during Friday’s pre-market trading session, after rival Eli Lily ’s Phase 3 ATTAIN-1 trial for obesity drug, orforglipron, trailed the Danish drug giant’s semaglutide on Thursday. Novo Nordisk Rivals Trail In Weight Loss Results The trial involving over 3,000 obese patients found that all three doses of orforglipron met the primary...
Iovance Biotherapeutics Declines 29% In Premarket Trading: Here's What's Happening
Iovance Biotherapeutics Declines 29% In Premarket Trading: Here's What's Happening
Aug 8, 2025
Iovance Biotherapeutics Inc. ( IOVA ) stock has declined by 29.92% in pre-market trading. This comes after the company reported its second-quarter financial results. Check out the current price of IOVA stock here.  What Happened: The stock of the California-based biotechnology company was trading at $2.64, up by $0.60 on Thursday, according to the Benzinga Pro data. However, this rise...
Copyright 2023-2026 - www.financetom.com All Rights Reserved